MIRA PHARMACEUTICALS, INC.
Qualité des données : 83%
MIRA
Nasdaq
Manufacturing
Chemicals
1,03 €
▼
0,01 €
(-0,96%)
Cap. Boursière: 43,28 M
Prix
1,03 €
Cap. Boursière
43,28 M
Fourchette du Jour
1,02 € — 1,07 €
Fourchette 52 Semaines
0,82 € — 2,45 €
Volume
74 261
Ouverture 1,04 €
Moyenne 50J / 200J
1,18 €
13,01% below
Moyenne 50J / 200J
1,38 €
25,49% below
Quick Summary
Points Clés
Negative free cash flow of -4,66 M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-257,23%
En dessous de la moyenne du secteur (-53,41%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
N/A
Current Ratio90,53
Interest CoverageN/A
Valorisation
PE (TTM)
-4,14
En dessous de la moyenne du secteur (-1,48)
P/B Ratio5,73
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1364 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,1 | -1,5 |
| P/B | 5,7 | 1,6 |
| ROE % | -257,2 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -10,44 M |
| ROE | -257,23% | ROA | -245,66% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4,66 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 90,53 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 7,51 M | Tangible Book Value | 7,55 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,14 | Forward P/E | N/A |
| P/B Ratio | 5,73 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -10,77% | ||
| Market Cap | 43,28 M | Enterprise Value | 40,64 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,35 | Revenue / Share | N/A |
| FCF / Share | -0,11 | OCF / Share | -0,11 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 44,64% |
| SBC-Adj. FCF | -6,69 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -10,44 M | -7,85 M | -11,98 M |
| EPS (Diluted) | -1,35 | -0,51 | -0,64 |
| Gross Profit | — | — | — |
| Operating Income | — | — | — |
| EBITDA | — | — | — |
| R&D Expenses | 1,72 M | 3,31 M | 1,57 M |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | 98 911,0 | -165 669,0 | 3,46 M |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 11,09 M | 2,92 M | 4,93 M |
| Total Liabilities | 702 068,0 | 723 349,0 | 558 097,0 |
| Shareholders' Equity | 10,39 M | 2,20 M | 4,37 M |
| Total Debt | — | — | — |
| Cash & Equivalents | 6,35 M | — | — |
| Current Assets | 11,06 M | 2,89 M | 4,86 M |
| Current Liabilities | 702 068,0 | 723 349,0 | 558 097,0 |
{"event":"ticker_viewed","properties":{"ticker":"MIRA","listing_kind":"stock","pathname":"/stocks/mira","exchange":"Nasdaq","country":"US"}}